The Advanced level of the Aleph Pharmaceutical Product Regulation course track is for professionals who already have the pharmaceutical regulatory vocabulary covered at orientation depth and need to develop the applied skills the industry expects: planning IND content for a chosen investigational product; mapping NDA, BLA, ANDA, or 505(b)(2) submissions into the Common Technical Document (CTD) modular structure; conducting cGMP gap analysis against 21 CFR Parts 210 and 211 at a manufacturing site; applying ICH Q8 Quality by Design with critical quality attributes and a control strategy; integrating ICH Q9 Quality Risk Management with development and manufacturing decisions; constructing ICH Q10 Pharmaceutical Quality System artifacts (management responsibility, process performance and product quality monitoring, CAPA, change management, management review); reviewing trial documents (protocol, informed consent, investigator brochure) for ICH GCP E6(R3) alignment; conducting applied pharmacovigilance signal analysis; and authoring an integrated pharmaceutical regulatory plan as a portfolio-grade deliverable.

This 32-hour Professional Certificate Course builds directly on the 16-hour Introductory level (`RAQ-640-I`). It does not repeat the pharmaceutical regulatory vocabulary orientation. Where the Introductory level identifies submission pathways, the Advanced level maps a chosen submission into CTD modules. Where the Introductory level identifies the ICH Q8 / Q9 / Q10 trio, the Advanced level applies each to a chosen pharmaceutical program. The course is organized around a chosen-program cumulative deliverable arc — the participant selects a pharmaceutical program in Module 1, builds regulatory content on it across Modules 2 through 8, and integrates everything into a capstone regulatory plan in Module 9.

Graduates of the Advanced course are positioned for senior applied work in Regulatory Affairs, Quality, Clinical Operations, and Pharmacovigilance roles at pharmaceutical and biologic manufacturers; at generics manufacturers; at CROs and CMOs/CDMOs; and at consultancies serving the pharmaceutical industry. The integrated pharmaceutical regulatory plan produced during the course is a portfolio-grade artifact.

Participants who meet the course completion requirements receive a Certificate of Completion issued by Aleph University.